Hourly refreshFri, Sep 25, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Finance

31,051 press releases indexed under finance.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · Healthcare

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for ...

(PR-inside.com) ~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~ SAN DIEGO, CA / ACCESS Newswire / September 24, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced the submission of the protocol for a Phase 2a clinical study of CY200, the Company's newest drug candidate from the newly acquired Cy Biopharma Inc. This landmark milestone involved the submission of protocol CYBIO_001 entitled "A Phase 2A, Multicenter, Randomised, ..

Sep 24 · 12:00PR-Inside
Finance · SaaS

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a ...

(PR-inside.com) Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indications Development funding is additional to the framework; Ainos retains core platform ownership, product supply opportunities and contractual participation in downstream commercial revenue HOUSTON, TX / ACCESS Newswire / September 24, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has entered into a VELDONA® License Agreement with BioPhoenix Co., Ltd. ("BioPhoenix"), establishing a collaboration framework with a potential aggregate value of $10 million. The framework comprises an initial license fee, conditional consideration for licenses covering 15 additional

Sep 24 · 12:00PR-Inside
Finance · SaaS

Cardiff Lexington Corporation Announces Letter of Intent for Proposed ...

(PR-inside.com) Proposed Combination Would Significantly Expand Cardiff Lexington's Musculoskeletal and Ancillary Healthcare Operations LEXINGTON, KY / ACCESS Newswire / September 24, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) ("Cardiff Lexington" or the "Company"), a healthcare holding company focused on orthopedics, spine care, pain management and related healthcare services, today announced that it has entered into a letter of intent ("LOI") with the owners of a multi-location musculoskeletal healthcare platform regarding a proposed business combination (the "Proposed Transaction"). The acquisition target (the "Target") operates an established comprehensive multi-location musculoskeletal healthcare platform serving patients in multiple states. The Company believes that the Propos

Sep 24 · 12:00PR-Inside
Finance · Media

Horizon Aircraft to Report First Quarter 2027 Results and Provide a ...

(PR-inside.com) Company Invites Investors to Submit Questions to be Answered on the Webcasted Earnings Call TORONTO, ON / ACCESS Newswire / September 24, 2026 / New Horizon Aircraft Ltd. ("Horizon Aircraft" or the "Company") (NASDAQ:HOVR) announces that it will release its financial results for the fiscal first quarter of 2027 on Friday, October 9, 2026, before market open. Management of the Company will discuss those results and provide a business update during a webcasted earnings call at 8:30 am ET on the same day. The webcast will feature a video presentation by Horizon Aircraft CEO Brandon Robinson and CFO Brian Merker. Guests can ..

Sep 24 · 12:00PR-Inside
Finance · SaaS

Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework

Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indications Development funding is additional to the framework; Ainos retains core platform ownership, product supply opportunities and contractual participation in downstream commercial revenue

Sep 24 · 12:00Newswire.com
Finance · Healthcare

Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging

Panel at Harvard University will explore translating evidence in diseases of aging into new therapeutics and regulatory pathways SEATTLE, Sept. 24, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company, today...

Sep 24 · 12:00mlpr-prnewswire-wire
Finance · SaaS

Cardiff Lexington Corporation Announces Letter of Intent for Proposed Acquisition of Leading Musculoskeletal Healthcare Platform

Proposed Combination Would Significantly Expand Cardiff Lexington's Musculoskeletal and Ancillary Healthcare Operations

Sep 24 · 12:00Newswire.com
Finance

Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026

Company Invites Investors to Submit Questions to be Answered on the Webcasted Earnings Call

Sep 24 · 12:00Newswire.com
Finance

Lyntris Qualifies Critical SPY-6 Radar Assembly, Strengthening the Supply Chain for Advanced Naval Radar

Two-year qualification effort in collaboration with Raytheon and the US Navy reduces supply chain risk as SPY-6 radar build rates increase. WASHINGTON, Sept. 24, 2026 /PRNewswire/ -- Lyntris Inc. (NYSE: LYNX), a defense technology company delivering sense-to-act connectivity solutions for...

Sep 24 · 12:00mlpr-prnewswire-wire
Finance · SaaS

FST Corp. Launches KBS TOUR V-X Steel Iron Shaft Family, Engineered for Best-in-Category Stability and Dispersion

Boulder, Colorado--(Newsfile Corp. - September 24, 2026) - FST Corp. (NASDAQ: KBSX) ("FST" or the "Company"), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced the launch of the KBS TOUR V-X family of steel iron shafts, comprising the KBS TOUR V-X and KBS TOUR V-X Lite.The V-X family represents the Company's newest steel iron shaft platform, engineered to maximize the strength-to-weight ratio while maintaining the...

Sep 24 · 12:00mlpr-newsfile
Finance · AI

POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model

GUANGZHOU, China, Sept. 24, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today highlighted its differentiated "hardware + AI + payment" infrastructure model. The...

Sep 24 · 12:00mlpr-prnewswire-wire
Finance · SaaS

HIFI Raises $37 Million to Build Tokenized Financial Infrastructure as Wall Street Moves Onchain

Led by Left Lane Capital, the Round Will Extend HIFI's Stablecoin Settlement Platform Into Tokenized Capital Markets and Card Issuance NEW YORK, NY - September 24, 2026 ( NEWMEDIAWIRE ) - HIFI , the financial infrastructure company for stablecoin payments and tokenized assets, today announced $37 million in Series A funding led by Left Lane Capital. The financing will support the scaling of HIFI’s tokenized capital markets infrastructure and the expansion of its broader product suite, including stablecoin payments and card products. HIFI was selected as a participant in DTCC's July production trades using DTC-tokenized assets, alongside BlackRock, Goldman Sachs and Nasdaq. In September, the company announced a partnership with Visa to expand money movement and card capabilities using its s

Sep 24 · 12:00NewMediaWire
← Prev123…2588Next →